                         SEQUENCE LISTING

<110>  Exerkine Corporation
 
<120>  EXOSOMES USEFUL TO TREAT LYSOSOMAL STORAGE DISEASE

<130>  H8312967PCT

<140>  PCT/CA2015/050959
<141>  2015-09-25

<150>  US 62/056125
<151>  2014-09-26

<150>  US 62/082853
<151>  2014-11-21

<150>  US 62/211204
<151>  2015-08-28

<160>  32    

<170>  PatentIn version 3.3

<210>  1
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  1

Gly Tyr Gln Ser Val 
1               5   


<210>  2
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  2

Gly Tyr Gln Thr Leu 
1               5   


<210>  3
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  3

Gly Tyr Gln Thr Ile 
1               5   


<210>  4
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  4

Gly Tyr Glu Val Met 
1               5   


<210>  5
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  5

Gly Tyr Glu Gln Phe 
1               5   


<210>  6
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  6

Ala Tyr Gln Ala Leu 
1               5   


<210>  7
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  7

Asn Tyr Thr His Leu 
1               5   


<210>  8
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  8

Gly Tyr Gln Arg Ile 
1               5   


<210>  9
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  9

Gly Tyr Asp Gln Leu 
1               5   


<210>  10
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  11

<400>  10

Gly Tyr Lys Glu Ile 
1               5   


<210>  11
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  11

Gly Tyr Arg His Val 
1               5   


<210>  12
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence


<220>
<221>  VARIANT
<222>  (2)..(3)
<223>  X is any amino acid

<400>  12

Asp Xaa Xaa Leu Leu 
1               5   


<210>  13
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence


<220>
<221>  VARIANT
<222>  (3)..(5)
<223>  X is any amino acid

<400>  13

Asp Glu Xaa Xaa Xaa Leu Leu Ile 
1               5               


<210>  14
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  14

Ser Phe His Asp Asp Ser Asp Glu Asp Leu Leu 
1               5                   10      


<210>  15
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  Lysosomal targeting sequence

<400>  15

Glu Glu Ser Glu Glu Arg Asp Asp His Leu Leu 
1               5                   10      


<210>  16
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  16

Gly Tyr His Asp Asp Ser Asp Glu Asp Leu Leu 
1               5                   10      


<210>  17
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  17

Ala Ser Val Ser Leu Leu Asp Asp Glu Leu Met 
1               5                   10      


<210>  18
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  18

Ala Ser Ser Gly Leu Asp Asp Leu Asp Leu Leu 
1               5                   10      


<210>  19
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  19

Val Gln Asn Pro Ser Ala Asp Arg Asn Leu Leu 
1               5                   10      


<210>  20
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  20

Asn Ala Leu Ser Trp Leu Asp Glu Glu Leu Leu 
1               5                   10      


<210>  21
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  21

Thr Glu Arg Glu Arg Leu Leu 
1               5           


<210>  22
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  22

Ser Glu Thr Glu Arg Leu Leu 
1               5           


<210>  23
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  23

Thr Asp Arg Thr Pro Leu Leu 
1               5           


<210>  24
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  24

Glu Glu Thr Gln Pro Leu Leu 
1               5           


<210>  25
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  25

Ile Thr Gly Phe Ser Asp Asp Val Pro Met Val 
1               5                   10      


<210>  26
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  26

Asp Glu Arg Ala Pro Leu Ile 
1               5           


<210>  27
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  27

Asn Glu Gln Leu Pro Met Leu 
1               5           


<210>  28
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  28

Asp Asp Gln Arg Asp Leu Ile 
1               5           


<210>  29
<211>  28
<212>  PRT
<213>  Homo sapiens

<400>  29

Met Ala Ala Pro Gly Ser Ala Arg Arg Pro Leu Leu Leu Leu Leu Leu 
1               5                   10                  15      


Leu Leu Leu Leu Gly Leu Met His Cys Ala Ser Ala 
            20                  25              


<210>  30
<211>  30
<212>  PRT
<213>  Mus sp.

<400>  30

Met Ala Ala Pro Gly Ala Arg Arg Pro Leu Leu Leu Leu Leu Leu Ala 
1               5                   10                  15      


Gly Leu Ala His Gly Ala Ser Ala Leu Phe Glu Val Lys Asn 
            20                  25                  30  


<210>  31
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  31

Ala Met Phe Met Val Lys Asn Gly Asn Gly 
1               5                   10  


<210>  32
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  lysosomal targeting sequence

<400>  32

Leu Phe Glu Val Lys Asn Asn Gly Thr Thr 
1               5                   10  


